HUMORAL IMMUNITY RESPONSES AFTER VACCINATION FOR HEPATITIS B VIRUS IN AUTOGRAFTED PATIENTS: A SINGLE CENTER EXPERIENCE

EHA Library, Naeema Al Musailem, 325572

DETECTION OF SARS-COV-2 INFECTION PREVALENCE IN 474 HEMATOLOGIC PATIENTS UNDER THERAPY WITH A TRIPLE SCREENING PROCEDURE INCLUDING TRIAGE, MOLECULAR NASOPHARYNGEAL SWAB AND RAPID SEROLOGICAL TEST.

EHA Library, Anna Candoni, 325573

COVID-19 INFECTION IN PATIENTS WITH HEMATOLOGICAL DISEASES IN BRAZIL: CLINICAL CHARACTERISTICS AND PROGNOSTIC FACTORS

EHA Library, Karina Tozatto Maio, 325576

CLINICAL OUTCOMES OF COVID-19 IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES TREATED IN THE COMMUNITY SETTING IN CROATIA

EHA Library, Hrvoje Holik, 325577

INFECTION BY SARS-COV-2 IN HEMATOLOGIC PATIENTS: AN UNICENTRIC RETROSPECTIVE STUDY

EHA Library, Ana Saraiva, 325578

MEASUREMENT OF VARICELLA ZOSTER IGG ANTIBODY IN CHILDREN TREATED FOR ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Yasmine El Chazli, 325579

A COMPARATIVE OUTCOME ANALYSIS OF COVID-19 VS INFLUENZA INFECTION IN PATIENTS WITH ACUTE LEUKEMIA

EHA Library, Franziska Modemann, 325583

RISK FACTORS AND OUTCOME OF SARS-COV-2 INFECTION IN HEMATOLOGIC PATIENTS – A SINGLE CENTER EXPERIENCE

EHA Library, Marino Narancic, 325584

THE ASSESSMENT OF IMPACT OF COVID-19 IN PATIENTS WITH ACUTE LEUKEMIA

EHA Library, Viola Popov, 325586

TREATMENT WITH REMDESIVIR, DEXAMETHASONE AND CONVALESCENT PLASMA TRANSFUSION IS SAFE AND BENEFICIAL IN HOSPITALIZED COVID-19 PATIENTS WITH HEMATOLOGICAL MALIGNANCIES.

EHA Library, Joanna Barankiewicz, 325587

SLOW INFUSION OF ANTI-THYMOCYTE GLOBULIN SIGNIFICANTLY DECREASED THE INCIDENCE OF REACTIONS AND THE NEED FOR CRITICAL CARE SERVICES

EHA Library, Moussab Damlaj, 325588

ARTERIAL AND VENOUS THROMBOTIC COMPLICATIONS IN HOSPITALIZED PATIENTS WITH COVID-19: EXPERIENCE FROM A MEXICO CITY HEALTH SYSTEM.

EHA Library, Lena Simental-Legarda, 325590

ACUTE LEUKEMIA AND SARS-COV-2 INFECTION: SINGLE CENTRE EXPERIENCE

EHA Library, Nikola Pantic, 325591

THE PROFILE OF FEBRILE NEUTROPENIA IN HEMATOLOGY-ONCOLOGY UNIT; EXPERIENCE OF CHILDREN WELFARE TEACHING HOSPITAL, MEDICAL CITY

EHA Library, Hasanein Ghali, 325592

HEMATOLOGIC CHARACTERISTICS AND C-REACTIVE PROTEIN OF PATIENTS WITH SARS-COV 2 ADMITTED TO A UNIVERSITY HOSPITAL IN BRAZIL.

EHA Library, Marina Dias, 325595

ALK2 IS A POTENTIAL THERAPEUTIC TARGET IN ANEMIA RESULTING FROM CHRONIC INFLAMMATION

EHA Library, Thomas Backus, 325597

DISC-B, A SELECTIVE MATRIPTASE-2 INHIBITOR, ELICITED ROBUST INCREASE IN HEPCIDIN-25 AND REDUCTION IN SERUM IRON IN CYNOMOLGUS MONKEYS

EHA Library, Vu Hong, 325599

ALK2 INHIBITION, A NOVEL THERAPEUTIC APPROACH TO IRON OVERLOAD.

EHA Library, Ffolliott Fisher, 325600

ANEMIA AND IRON METABOLISM IN PATIENTS WITH SARS-COV-2 INFECTION: THE ROLE OF INFLAMMATION AND HYPOXIA.

EHA Library, Diletta Maira, 325601

TMPRSS6 POLYMORPHISMS AND A RISK OF IRON DEFICIENCY ANEMIA IN SCHOOL-AGED CHILDREN

EHA Library, Rawinun Udomponglukkana, 325608

COMPREHENSIVE CHARACTERIZATION OF THE MUTATIONAL LANDSCAPE IN EPSTEIN-BARR VIRUS-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA BY WHOLE-GENOME AND TARGETED AMPLICON-BASED SEQUENCING

EHA Library, Hanno M Witte, 325611

DISEASE AND OUTCOME ASSOCIATED IMMUNE SIGNATURES AT DIAGNOSIS IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Edward Truelove, 325612

ROLE OF PROTEIN KINASES CK1 ALPHA AND CK2 IN CHRONIC ACTIVE BCR-DEPENDENT SIGNALING NETWORK IN MANTLE CELL LYMPHOMA: EFFECTS ON BTK-DIRECTED THERAPY.

EHA Library, Sabrina Manni, 325613

HIGH RISK AGGRESSIVE B-CELL LYMPHOMA ON THE LIQUID BIOPSY

EHA Library, Leo Meriranta, 325614

A SIMPLE EPIGENETIC SIGNATURE DEFINES TWO BIOLOGIC GROUPS OF MANTLE CELL LYMPHOMA

EHA Library, Marco Bühler, 325616

EZH2 INHIBITOR TAZEMETOSTAT DEMONSTRATES ACTIVITY IN PRECLINICAL MODELS OF BRUTON’S TYROSINE KINASE INHIBITOR-RESISTANT MANTLE CELL LYMPHOMA

EHA Library, Alejandra Raimondi, 325617

NEXT GENERATION SEQUENCING PROVIDES NOVEL MOLECULAR MARKERS FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA: BIOLOGICAL RESULTS FROM FONDAZIONE ITALIANA LINFOMI (FIL) FOLL12 TRIAL

EHA Library, Simone Ferrero, 325618

A CIRCULAR RNA EXPRESSION SIGNATURE PREDICTS DISMAL OUTCOME IN MANTLE CELL LYMPHOMA: A STUDY OF YOUNGER PATIENTS FROM THE NORDIC MCL2 AND MCL3 CLINICAL TRIALS

EHA Library, Mette Dahl, 325621

PLK4 INHIBITION BY CFI-400945 ENHANCES DOXORUBICIN SENSITIVITY IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Yi Zhao, 325623

SUPPRESSION OF NUSAP1 INHIBITS CELL PROLIFERATION IN DIFFUSE LARGE B-CELL LYMPHOMA THROUGH DNA DAMAGE REPAIR PATHWAY

EHA Library, Yang Han, 325624

SERUM EXOSOMAL MICRORNAS AS NOVEL NON-INVASIVE BIOMARKERS FOR DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Jiarui Liu, 325626

DISCOVERY AND PRECLINICAL PROPERTIES OF JNJ-64264681, A POTENT AND SELECTIVE COVALENT BTK INHIBITOR FOR THE TREATMENT OF B CELL MALIGNANCIES

EHA Library, Ulrike Philippar, 325627

ANALYSIS OF EZH2 MUTATIONS IN SOLID AND LIQUID BIOPSY AND ITS ROLE AS PREDICTIVE MARKER FOR CHEMOTHERAPY IN PATIENTS WITH FOLLICULAR LYMPHOMA

EHA Library, Mariana Bastos-Oreiro, 325628

MELPHALAN FLUFENAMIDE IS A HIGHLY POTENT ANTI-NEOPLASTIC AGENT IN HIGH RISK DLBCL MODELS

EHA Library, Konstantin Byrgazov, 325629

GENOMEWIDE COPY NUMBER ANALYSIS OF GRADE 1-3A, 3B, AND COMPOSITE FOLLICULAR LYMPHOMA

EHA Library, Pablo Mozas, 325630

XENOGRAFT MODELLING OF DRIVING MOLECULAR EVENTS IN BURKITT LYMPHOMA

EHA Library, Simon Bomken, 325634

CHN1 IS A NOVEL PROGNOSTIC MARKER FOR DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Jie Sun, 325635

EXPRESSION AND CLINICAL SIGNIFICANCE OF STING IN T- AND NK-CELL NON HODGKIN LYMPHOMAS

EHA Library, Ioanna Xagoraris, 325640

SERUM MIR-22 AS NOVEL NON-INVASIVE PREDICTOR OF CLINICAL OUTCOME AND RESPONSE TO THERAPY IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Francesco Marchesi, 325641

DIFFERENT ABDOMINAL FAT COMPARTMENTS DIFFERENTLY REFLECT ON PROGNOSIS IN CLASSICAL HODGKIN LYMPHOMA PATIENTS

EHA Library, Marko Lucijanic, 325644

TRITON X-114 AND AMINE-BASED WASH STRATEGY REDUCES LPS TO FDA-LIMIT AND ACHIEVES PURER, MORE POTENT RECOMBINANT IMMUNOTOXIN.

EHA Library, Rebekka George, 325645

MOLECULAR AND CYTOGENETIC CHARACTERIZATION OF MYELODYSPLASTIC SYNDROMES IN CELL-FREE DNA

EHA Library, Nieves Garcia-Gisbert, 325648

ALL-TRANS RETINOIC ACID ENHANCES THE CYTOTOXIC EFFECT OF DECITABINE ON MYELODYSPLASTIC SYNDROMES VIA ACTIVATING RARΑ-NRF2 COMPLEX

EHA Library, Lu Wang, 325649

LESS CAN BE MORE – GENDER-RELATED MUTATIONAL LANDSCAPE AND OUTCOME IN MYELODYSPLASTIC SYNDROME

EHA Library, Manja Meggendorfer, 325650

CLONAL HEMATOPOIESIS IS COMMON IN HIP ARTHROPLASTY PATIENTS AND ASSOCIATES WITH AUTOIMMUNE DISEASE AND LOWER HEMOGLOBIN LEVELS

EHA Library, Judith S. Hecker, 325654

THE CAR VIRUS RECEPTOR MEDIATES MATURATION AND MIGRATION IN ERYTHROID PRECURSOR CELLS AND IS DOWNREGULATED IN MDS

EHA Library, Karin Bauer, 325655

UNCLASSIFIABLE MYELODYSPLASTIC SYNDROME DEFINED BY A CYTOGENETIC ABNORMALITY: A REAL-LIFE STUDY.

EHA Library, Victor-Emmanuel Brett, 325656

USING TISSUE MICROARRAY TO DETECT INFLAMMASOME SIGNALING COMPONENTS THAT CONTRIBUTE TO THE PATHOGENESIS OF MYELODYSPLASTIC SYNDROME

EHA Library, Tony Kurian, 325657

PIM INHIBITORS INDUCE THE FERROPTOSIS VIA HIF1A/GPX4 PATHWAY IN HEMATOLOGICAL MALIGNANT CELLS

EHA Library, Rong Fu, 325658

BMSCS REGULATE THE FUNCTION OF NK CELL BY CD155/TIGIT/CD226 PATHWAY IN MDS PATIENTS

EHA Library, Zhaoyun Liu, 325659

PHARMACOLOGIC INHIBITORS OF CDK4/CDK6 EXERT ANTI-NEOPLASTIC EFFECTS ON CMML CELLS AND SYNERGIZE WITH THE MULTI-KINASE INHIBITOR PONATINIB IN NEOPLASTIC MONOCYTES

EHA Library, Max V. John, 325660

THE PIVOTAL ROLE OF WEE1 AND PARP-1 IN MYELODYSPLASTIC SYNDROME (MDS): A NEW STRATEGY FOR THE TARGETED THERAPY OF MDS

EHA Library, Seiichi Okabe, 325661

PREVALENCE OF UBA1 MUTATIONS IN MDS/CMML PATIENTS WITH SYSTEMIC INFLAMMATORY AND AUTO-IMMUNE DISEASE

EHA Library, Lin-Pierre Zhao, 325664

MESENCHYMAL STROMAL CELLS AS A POTENTIAL THERAPEUTIC TOOL IN ENHANCING RESIDUAL HEALTHY HAEMATOPOIESIS IN LOW-RISK MDS PATIENTS

EHA Library, Tamara Jiménez, 325665

SIMPLE FLOW CYTOMETRY IMMUNOPHENOTYPING APPROACH PREDICTS THE DEVELOPMENT OF MYELOID NEOPLASMS IN PATIENTS WITH CCUS

EHA Library, Dragan Jevremovic, 325666

VENETOCLAX AND AZACITIDINE COMBINATION IN CHEMOTHERAPY INELIGIBLE PATIENTS WITH THERAPY-RELATED MYELOID NEOPLASMS, ANTECEDENT MYELODYSPLASTIC SYNDROMES OR MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Vinod A. Pullarkat, 325667

HUMAN ERYTHROID PROGENITORS ARE DIRECTLY INFECTED BY SARS-COV-2: IMPLICATIONS FOR EMERGING ERYTHROPOIESIS IN SEVERE COVID19 PATIENTS

EHA Library, Hector HUERGA ENCABO, 325571

COVID-19 INFECTION IN MULTIPLE MYELOMA PATIENTS – CZECH EXPERIENCE

EHA Library, Jakub Radocha, 325574

EPIDEMIOLOGY AND MORTALITY IN BACTERAEMIA IN ADULT PATIENTS WITH HEMATOLOGIC MALIGNANCIES

EHA Library, BECHIR ACHOUR, 325575

INVASIVE ASPERGILLOSIS IN HEMATOLOGICAL PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SINGLE-CENTER STUDY

EHA Library, Yuliya Rogacheva, 325580

IMPACT OF ADEQUATE EMPIRICAL BROAD-SPECTRUM ANTIBIOTIC FOR BLOODSTREAM INFECTION IN PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE

EHA Library, Miguel Angel Rodriguez Gil, 325581

IMPACT OF THE ABCB1 DRUG RESISTANCE GENE ON COMPLICATIONS ASSOCIATED WITH COVID-19

EHA Library, Christian Ramos, 325582

ROLE OF ERYTHROPOIESIS STIMULATING AGENTS (ESAS) IN SUPPORTIVE CARE OF LOW-RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Claudio Cerchione, 325585

ANTIBIOTIC-RESISTANT GRAM-NEGATIVE BACTERIAL INFECTIONS IN PATIENTS WITH HEMATOLOGIC MALIGNANCY

EHA Library, BECHIR ACHOUR, 325589

AUDIT OF CHEMOTHERAPY DISRUPTION DUE TO COVID19 PANDEMIC: PERSPECTIVE FROM A UK DISTRICT GENERAL HOSPITAL

EHA Library, Aldalaq Ahmad, 325593

COMPLICATION, ASSOCIATED WITH CATHETERISATION OF CENTRAL VEIN IN HEMATOLOGY PATIENTS

EHA Library, Nikolay Romanenko, 325594

GROWTH OF ANTIBIOTIC RESISTANCE IN THE HEMATOLOGY DEPARTMENT OF CENTRAL KAZAKHSTAN DURING THE COVID-19 PANDEMIC

EHA Library, Ludmila Turgunova, 325596

ADMINISTRATION OF ALK2 NEUTRALIZING ANTIBODIES TO CYNOMOLGUS MONKEYS LED TO A SUSTAINED DECREASE IN HEPCIDIN, INCREASE IN CIRCULATING IRON AND INCREASE IN ERYTHROCYTE HEMOGLOBIN

EHA Library, Claire C Tseng, 325598

ERYTHROFERRONE, THE MEDIATOR BETWEEN ERYTHROPOISESIS, HEPCIDIN AND IRON METABOLISM, DURING ALLOGENIEC HEMATOPOIETIC STEM CELLS TRANSPLANT.

EHA Library, Michelle Pirotte, 325602

EFFICACY OF IRON SUPPLEMENTS GIVEN ON ALTERNATE DAYS VERSUS CONSECUTIVE DAYS IN THE TREATMENT OF IRON DEFICIENCY ANEMIA IN WOMEN OF REPRODUCTIVE AGE: NON-INFERIORITY, RANDOMIZED CONTROLLED TRIAL

EHA Library, Sasinipa Trithiphen, 325603

NON-CLINICAL SAFETY OF SLN124, A GALNAC CONJUGATED 19-MER DOUBLE-STRANDED SIRNA TARGETING TMPRSS6 FACILITATING EVALUATION IN CLINICAL STUDIES

EHA Library, Simon Chivers, 325604

PRE-TRANSPLANT HYPERFERRITINEMIA CANNOT PREDICT TRANSPLANT OUTCOMES IN HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANT FOR SEVERE APLASTIC ANEMIA

EHA Library, Fan Lin, 325605

CHANGES IN ERYTHROPOIESIS IN MALARIA-INDUCED ANEMIA

EHA Library, Raffaella Gozzelino, 325606

RELATIONSHIP OF PRE-TRANSPLANT IRON STATUS TO OUTCOMES POST KIDNEY TRANSPLANTATION : A RETROSPECTIVE COHORT

EHA Library, Jan Joel Simpauco, 325607

DISSECTION OF MANTLE CELL LYMPHOMA BONE MARROW B LYMPHOCYTES ON THE SINGLE-CELL LEVEL WITH FOCUS ON CLINICAL MARKERS AND SOXC FAMILY MEMBERS

EHA Library, Simone Valentin Hansen, 325609

WHOLE-GENOME CRISPR LIBRARY SCREENS IDENTIFY CD48 AS AN ESSENTIAL MOLECULE IN ADULT T-CELL LEUKEMIA/LYMPHOMA FOR DEFINING SUSCEPTIBILITY TO NATURAL KILLER CELL-MEDIATED CYTOTOXICITY

EHA Library, Masahiro Chiba, 325610

DDX3X LOSS IS ASSOCIATED WITH AGGRESSIVE PHENOTYPES IN NON-HODGKIN’S LYMPHOMAS

EHA Library, Atish Kizhakeyil, 325615

PRMT5 INHIBITION RESTARTS A PRO-APOPTOTIC PROGRAM AND CREATES VULNERABILITY TO COMBINATION TREATMENT WITH BCL-2 INHIBITOR VENETOCLAX IN MANTLE CELL LYMPHOMA

EHA Library, Fiona Brown, 325619

TARGETING GLYCOPROTEIN PTGDS INHIBITS THE PROGRESSION OF DIFFUSE LARGE B-CELL LYMPHOMA THROUGH MYH9-WNT-Β-CATENIN/STAT3 AXIS

EHA Library, Shunfeng Hu, 325620

IDENTIFICATION OF M6A METHYLTRANSFERASE KIAA1429 AS A POTENTIAL TARGET IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Xiaomin Chen, 325622

TIGIT EXPRESSION AND ITS SCORING SYSTEM IN CLASSIC HODGKIN LYMPHOMA: A NOVEL THERAPEUTIC TARGET?

EHA Library, Ombretta Annibali, 325625

T-CELL SUBSET COMPOSITION AND FUNCTIONALITY IN PATIENTS WITH WALDENSTRÖM’S MACROGLOBULINEMIA.

EHA Library, Karima Amaador, 325631

BERBERINE EXERTS IMMUNOREGULATING FUNCTION IN DIFFUSE LARGE B-CELL LYMPHOMA VIA DOWNREGULATING CD47 EXPRESSION

EHA Library, Shuai Ren, 325632

ABERRANT EPIGENETIC REGULATION THROUGH METABOLIC REPROGRAMMING IN ATL LEUKEMOGENESIS

EHA Library, Tatsuro Watanabe, 325633

CCL2-CCR2 AXIS SIGNALING PROMOTES DIFFUSE LARGE B-CELL LYMPHOMA CELL SURVIVAL AND INVASION

EHA Library, Yan-Li Li, 325636

LENALIDOMIDE-INDUCED EFFECTS ON CELL SURFACE EXPRESSION OF CD19 AND CD20 IN DLBCL CELL LINES AND FUNCTIONAL IMPACT ON ANTIBODY-MEDIATED CYTOTOXICITY

EHA Library, Maria Patra-Kneuer, 325637

LOW PERCENTAGE OF T-LYMPHOCYTES IN FOLLICULAR LYMPHOMA LYMPH NODE BIOPSIES, MEASURED BY FLOW CYTOMETRY, IS ASSOCIATED WITH INFERIOR PROGRESSION FREE SURVIVAL.

EHA Library, Laura Korin, 325638

PROGNOSTIC ROLE OF CD30 FROM A RETROSPECTIVE REVIEW OF 295 PATIENTS WITH ANGIOIMMUNOBLASTIC T CELL LYMPHOMA

EHA Library, Julia Parrish, 325639

TUMOR MICROSATELLITE ANALYSIS IN B-CELL LYMPHOMAS

EHA Library, Sychevskaya Kseniia, 325642

RELIABLE DETECTION OF T-CELL CLONALITY BY FLOW CYTOMETRY IN MATURE T-CELL NEOPLASMS USING TCR Β CONSTANT REGION 1 (TRBC1): A COMPARISON WITH PCR BASED CLONALITY TESTING.

EHA Library, Deirdre Waldron, 325643

IMPLICATIONS OF THE SPLICEOSOME MUTATION U2AF1 FOR THE EXPRESSION OF CIRCULAR RNA

EHA Library, Eileen Wedge, 325646

MYELODYSPLASTIC SYNDROME IN YOUNG ADULT WITHOUT PREVIOUS ORGANIC DISFUNCTION: PREDOMINANCE OF GERMLINE VARIANTS IN GENES OF DNA REPAIR PATHWAY AND THEIR CLINICAL IMPACT

EHA Library, Tzu-Hua Chen Liang, 325647

COHESIN MUTATIONS ARE ASSOCIATED WITH A POOR PROGNOSIS PHENOTYPE AND A WORSE CLINICAL OUTCOME IN LOW-RISK MYELODYSPLASTIC SYNDROMES PATIENTS

EHA Library, Marta Martín Izquierdo, 325651

SINGLE-CELL RNA SEQUENCING TO EXPLORE THE ABNORMAL DIFFERENTIATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS IN MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA

EHA Library, Yumei Liu, 325652

LNCRNA PCSK1N-202 PROMOTES CD34+CELL PROLIFERATION VIA PIM2/HIF-1Α IN MYELODYSPLASTIC SYNDROMES

EHA Library, Zhaoyun Liu, 325653

AZACITIDINE SEQUENCED WITH RIGOSERTIB DOWNREGULATES NEGATIVE REGULATORS OF HEMATOPOIESIS INCLUDING MULTIPLE MAPK PATHWAYS IMPACTING STEMNESS/DIFFERENTIATION OF MDS-L CELLS WITH CLINICAL IMPLICATIONS

EHA Library, Richa Rai, 325662

PHENOTYPIC AND GENETIC FEATURES OF MYELODYSPLASTIC SYNDROME (MDS) BONE MARROW (BM) DERIVED MESENCHYMAL STROMAL CELLS (MSC) FOR DISEASE PROGNOSIS AND THERAPY

EHA Library, Zhiyong Poon, 325663

EFFICACY OF IMETELSTAT IS INDEPENDENT OF MOLECULAR SUBTYPES IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER RISK MDS (LR-MDS) RELAPSED/REFRACTORY (R/R) TO ERYTHROPOIESIS STIMULATING AGENTS (ESA)

EHA Library, Uwe Platzbecker, 325668

A MACHINE LEARNING APPROACH TO PREDICTING RISK OF MYELODYSPLASTIC SYNDROME

EHA Library, Ashwath Radhachandran, 325669

THERAPY-RELATED MDS; A WIDE DEFINITION THAT NEEDS NARROWING

EHA Library, Daniel Berggren, 325670